-- 
Atenor, Hamon, Spyker, Ten Cate, UCB: Benelux Equity Preview

-- B y   M a u d   v a n   G a a l   a n d   J o h n   M a r t e n s
-- 
2011-03-02T05:00:02Z

-- http://www.bloomberg.com/news/2011-03-01/atenor-hamon-spyker-ten-cate-ucb-benelux-equity-preview.html
The following companies may have
unusual price changes in Benelux markets. Stock symbols are in
parentheses, and prices are from the previous close.  The  AEX-Index  in Amsterdam declined 1.18, or 0.3 percent,
to 367.95.  Belgium ’s Bel20 Index gained 5.58, or 0.2 percent, to
2,712.67. Luxembourg’s LuxX Index lost 0.1 percent to 1,512.04.  Dutch stocks:  Royal Ten Cate NV (KTC NA): The Dutch supplier of fabric
for flame-resistant U.S. Army uniforms may report full-year net
income rose to 43.7 million euros ($60.3 million), according to
the average estimate of six analysts surveyed by Bloomberg. Ten
Cate climbed 2.4 percent to 26.98 euros.    Spyker Cars NV  (SPYKR NA): The automaker’s sports-car unit
will be profitable in 2013, Vladimir Antonov, who’s buying the
division, said in an interview in Geneva.  Spyker’s Saab Automobile division aims to sell 30,000 cars
in the U.S., Chief Executive Officer Victor Muller said in the
joint interview. Spyker fell 2.9 percent to 5.05 euros.  Belgian stocks:    Atenor Group  SA (ATEB BB): The real-estate developer cut
its dividend 23 percent to 2 euros a share following a loss last
year and said it bought a 5.4-hectare site in Anderlecht,
Belgium, for an undisclosed sum. Atenor advanced 0.6 percent to
33.25 euros.  Hamon & Cie. SA (HAMO BB): The French-Belgian maker of
cooling towers for power stations reported full-year net income
fell 33 percent to 11.7 million euros and said it won orders
valued at 449.7 million euros last year, a 49 percent increase
from a year earlier. Hamon increased 2.9 percent to 29.48 euros.    UCB SA  (UCB BB): Belgium’s biggest drugmaker may report
full-year profit excluding some items of 1.805 euros per share,
according to the average of 20 analyst estimates compiled by
Bloomberg. UCB declined 0.3 percent to 26.86 euros.  To contact the reporters on this story:
Maud van Gaal in Amsterdam at =31-20-589-8530 or
 mvangaal@bloomberg.net ;
John Martens in Brussels at 
 jmartens1@bloomberg.net   To contact the editors responsible for this story:
Frank Connelly at   fconnelly@bloomberg.net ;
Angela Cullen at   acullen8@bloomberg.net . 